Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT04709016 Completed - Drug Dependence Clinical Trials

Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME

CONSUME
Start date: March 18, 2021
Phase:
Study type: Observational

This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).

NCT ID: NCT04707599 Completed - Clinical trials for Substance-Related Disorders

Telephone Reminder to Increase Appointment Rates

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

Missed appointments to outpatient substance use treatment are common and costly and can have a negative effect on the health of patients. In this quasi-experimental study, the investigators used an on-off design to examine whether a reminder "plus" intervention (telephone call from therapist before first appointment) would increase attendance and improve cancellation and rebooking practices. Secondary outcomes included satisfaction with treatment and intention to complete the treatment program.

NCT ID: NCT04700696 Completed - Substance Abuse Clinical Trials

Enhancing Permanency in Children and Families

EPIC
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The Enhancing Permanency in Children and Families (EPIC) program is a collaborative effort between the Ohio State University College of Social Work, two county offices of the Ohio Department of Job and Family Services, two juvenile courts and local behavioral health agencies. The goal of EPIC is to use three evidence-based and evidence-informed practices to reduce abusive and neglectful parenting, reduce addiction severity in parents, and improve permanency outcomes for families involved with the child welfare system due to substance abuse.

NCT ID: NCT04693416 Completed - Opioid Use Clinical Trials

SMART Trial: Intrapersonal and Interpersonal Stigma Reduction

Start date: March 8, 2021
Phase: Phase 2
Study type: Interventional

The goal of this project is to develop a multicomponent stigma reduction intervention to address intrapersonal (individual) stigma regarding Opioid Use Disorder (OUD). The intervention will address this cost/benefit evaluation among individuals known to face intersecting stigma of OUD and African American race, with treatment elements chosen explicitly to increase the value of treatment using salient forms of reward, and to ease perceived costs through explicit services in an effort to encourage the occurrence of the first treatment visit for OUD.

NCT ID: NCT04661228 Completed - Clinical trials for Substance Use Disorders

Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)

PsykHUNT
Start date: November 2, 2018
Phase:
Study type: Observational

The aims of this observational survey are to i) gather experience on how to conduct a prevalence study of mental disorders in the Norwegian setting, ii) collect data on the prevalence, risk factors and consequences of mental and substance use disorders, iii) collect data on treatment coverage for mental and substance use disorders, iv) conduct a thorough nonparticipation analysis.

NCT ID: NCT04659954 Completed - Clinical trials for Substance-Related Disorders

Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction

FA-O'DIDE
Start date: January 7, 2022
Phase: N/A
Study type: Interventional

Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this within SUD management, it is important to establish a confident relation between the patient and the care team to favorize acre observance. However, it demands an important availability of the healthcare team, allowing for frequent interactions at all times, including at night and during days off. With the present study, the investigator postulated that an application called Ô DIDE for Digital Interaction for Detoxification Engagement, that aims to help the caregivers maintaining a link with the patient in order to facilitate confidence in the relationship, could favorize care observance especially consumption report.

NCT ID: NCT04656899 Completed - Opioid-use Disorder Clinical Trials

Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study

MAP4BUP
Start date: December 6, 2020
Phase: N/A
Study type: Interventional

The investigators will conduct a phase I study involving 41 participants selected randomly among patients prescribed buprenorphine-naloxone for opioid misuse as a feasibility trial of the study of the Pillsy device. The study will track the effectiveness of the Pillsy technology and associated smartphone application by measuring adherence to buprenorphine-naloxone therapy and patient satisfaction with the application and the Pillsy device.

NCT ID: NCT04637815 Completed - Substance Use Clinical Trials

A Social Network AOD Intervention for Homeless Youth Transitioning to Housing

Start date: February 9, 2021
Phase: Phase 1
Study type: Interventional

This project will pilot test a computer-assisted social network intervention, using motivational interviewing techniques, that can help case managers work with formerly homeless young adults who recently transitioned to supportive housing to reduce substance use and increase permanent supportive connections during this critical transitional period.

NCT ID: NCT04634968 Completed - Adolescent Behavior Clinical Trials

Peer-delivered Follow-up Text Communication After a Brief Motivational Interviewing (MI) for Adolescent Drug Abusers

Start date: November 15, 2020
Phase: N/A
Study type: Interventional

A pilot randomized control trial will be conducted attaching to the MedPAC services to evaluate the feasibility and acceptability of a Motivational Interviewing (BMI) interaction via instant messaging apps on reducing the drug abuse among youth in Hong Kong.

NCT ID: NCT04630249 Completed - Depression Clinical Trials

Pilot Randomized Controlled Trial (RCT): Remote SBIRT Vs. In-Person SBIRT

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

Specific Aim 1: Conduct a pilot, small-scale randomized controlled trial to examine feasibility and preliminary efficacy of LTW, compared to TAU. Outcomes related to feasibility include percentage of eligible patients recruited, study attrition, study retention, and mental health and substance use treatment appointment attendance. Outcomes related to preliminary efficacy will include participation in screening, referral and treatment as well as reduction in mental health and substance use at 1 and 3 months post-study enrollment, compared to TAU. Specific Aim 2: Conduct a randomized controlled trial to examine the effectiveness of LTW, compared to TAU. Outcomes related to effectiveness include attendance to treatment as well as reduction in mental health and substance use at 1 and 3 months post-study enrollment, compared to TAU.